市场调查报告书
商品编码
1504259
全球压力治疗市场评估:依产品、技术、应用、最终用户、分销管道、地区、机会、预测(2017-2031)Compression Therapy Market Assessment, By Product, By Technology, By Applications, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F |
全球压力治疗市场规模预计将从2023年的 40.1 亿美元增至2031年的 59.4 亿美元,预计2024-2031年的年复合成长率为 5.03%。淋巴水肿患者数量的增加、新产品的推出、策略联盟和合作伙伴关係以及运动伤害数量的增加支持了市场的成长。
人们越来越认识到压力疗法在有效管理和治疗腿部溃疡、静脉曲张和淋巴水肿等各种疾病方面的好处,为市场创造有利的成长机会。医疗保健专业人员也建议对各种其他情况进行加压治疗,包括深部静脉血栓形成高风险的患者。透过各种分销管道增加压力治疗产品的可用性,使这些产品易于采购,为消费者带来了便利,对市场成长产生了积极影响。
先进产品和解决方案的开发以及美国食品和药物管理局(FDA)的批准进一步支持市场扩张。2023年 4月,Airos Medical, Inc. 的 AIROS 8P 顺序压缩治疗服装系统和设备获得美国 FDA 510(k)许可。此次批准使 Airos 能够提供小腿三头肌服装来治疗腹部肿胀。这款服装非常适合臀部、小腿、背部和腹部淋巴水肿患者。 AIROS 8P还具有升级的AC100-240V电气功能和更大的气泵,这使得该设备可以在全球不同地区使用,特别是为亚太和欧洲等地区的产品扩展铺平了道路。此类开发和批准预计将帮助公司扩大和增加对全球压力治疗市场的需求。
运动伤害的增加增强了市场需求
儿童和青少年日益参与体育活动,并且由于参与这些活动增加了受伤的可能性并增加了对治疗解决方案的需求,因此对压力疗法的需求也在增加。父母鼓励儿童和青少年参与体育活动,因为他们越来越意识到体育活动带来的许多好处,包括增强体质、性格发展、自尊和领导能力。这种参与的增加增加了对压力疗法的需求,以有效控制因运动相关损伤的发生而引起的疼痛。约翰霍普金斯大学医学院估计,美国约有 3,000 万名青少年和儿童参加有组织的运动,约三分之一的儿童伤害是由运动造成的。这种增加增加了对各种压缩疗法的需求,这些疗法可以减少肿胀和炎症,并减少创伤周围软组织的内部损伤。
新产品的推出推动市场成长
随着新产品的推出提高了消费者的舒适度,增强了提供更高功效的产品的可用性,并使公司能够扩大客户群,预计全球压力治疗市场将促进该市场的成长2024年 2月,专门从事非侵入性患者监测、疼痛管理和復健医疗设备销售和製造的领先创新医疗技术公司 Zynex, Inc. 宣布推出 Zynex DynaComp Cold Compression 和 Zynex Pro Hybrid LSO。前者结合了压力疗法和冷疗法来加速恢復,并且结构紧凑且便于携带,可以在旅途中缓解发炎、疼痛和肿胀。这使得患者能够更快地康復并更容易恢復日常活动。这些举措使公司能够确保可持续成长并实现收入来源多元化,推动成长并支持市场扩张。
本报告研究和分析了全球压力治疗市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
Global compression therapy market is projected to witness a CAGR of 5.03% during the forecast period 2024-2031, growing from USD 4.01 billion in 2023 to USD 5.94 billion in 2031F. The growth of the market is aided by the growing cases of lymphedema, novel product launches, strategic collaborations and partnerships, and a rise in the number of sports-related injuries.
The growing awareness about the advantages of compression therapies in the effective management and treatment of various conditions, such as leg ulcers, varicose veins, and lymphedema, among others, is providing lucrative growth opportunities to the market. Healthcare professionals also recommend compression therapy for various other conditions, including those at a high risk of deep vein thrombosis. The rising availability of compression therapy products across different distribution channels enhances consumer convenience by allowing easy procurement of these products, positively influencing the growth of the market.
The development of advanced products and solutions and receipt of clearance from the U.S. Food and Drug Administration (FDA) further support the expansion of the market. In April 2023, Airos Medical, Inc. received U.S. FDA 510(k) clearance to market their AIROS 8P Sequential Compression Therapy garment system and device. This clearance allowed AIROS to provide lower truncal garments to treat abdominal swelling. The garment is ideal for patients with lymphedema in their hips, lower legs, back, and abdomen. The AIROS 8P also features upgraded 100-240 VAC electrical capabilities and a larger air pump, allowing the device to be used in different regions across the globe and paving the way for the expansion of the product in regions such as Asia-Pacific and Europe, among others. Such developments and clearances are expected to aid the expansion of the companies and augment the global compression therapy market demand.
Rising Sports Injuries Bolsters Market Demand
The rising adoption of sports activities among children and teenagers propels the demand for compression therapy as participation in these activities augments the chances of injuries and boosts the requirement for treatment solutions. Due to the growing awareness about the various advantages offered by these activities in improving the physical fitness of children and teenagers while positively influencing their personal development and increasing self-esteem and leadership skills, parents are encouraging participation in these activities. This increased participation augments the requirement for compression therapy for the effective management of pain that can be caused by the occurrence of sports-related injuries. According to estimates from Johns Hopkins Medicine, approximately 30 million teenagers and children participate in organized sports in the United States and about one-third of the injuries procured during childhood are caused by sports. This increase is propelling the requirement for various compression therapies as they aid in reducing swelling and inflammation and also reduce internal injuries in the soft tissue that surrounds the external injury.
New Product Launches Boost Market Growth
Novel product launches are expected to fuel the global compression therapy market growth as they enhance consumer comfort and bolster the availability of products that offer enhanced effectiveness, allowing businesses to expand their customer base. In February 2024, Zynex, Inc., one of the leading innovative medical technology companies that specialize in the sale and manufacture of non-invasive patient monitoring, pain management, and rehabilitation medical devices, introduced Zynex DynaComp Cold Compression and Zynex Pro Hybrid LSO. The former combines compression and cold therapy to accelerate recovery time, and its portable and compact nature makes it easy to carry, providing on-the-go muscle relief from inflammation, soreness, and swelling. Thus, aiding patients in recovering faster and allowing them to restart their daily schedules with ease. Such efforts allow companies to ensure sustained growth and diversify revenue streams, propelling their growth and supporting the expansion of the market.
North America Anticipated to Account for Significant Market Share
Rising government initiatives support the growth of the market in North America, the growing prevalence of chronic diseases, new product launches, the rising number of sports-related injuries, and increasing investments in research and development activities. In November 2022, the U.S. House of Representatives passed H.R. 3630, the Lymphedema Treatment Act. This bill will improve the accessibility of medical compression garments for patients with lymphedema who rely on the products for treating their swelling. The utilization of medical compression garments aids in improving the quality of life and health of patients by reducing the requirement for hospitalization and the risk of infections, while protecting the patients from various complications. The federal law was passed in December 2022 and went into effect in January 2024 to improve the insurance coverage of prescribed compression supplies essential for treating lymphedema.
Additionally, the growing number of cases of diabetes and rising obesity in various countries in North America are further supporting the expansion of the market in the region, as such conditions often lead to circulatory issues, resulting in an increased demand for compression therapy products. According to estimates from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 11.6% of the population of the United States had diabetes in 2021.
Compression Bandages Hold Significant Global Compression Therapy Market Share
The segment's growth can be attributed to the expansion of the geriatric population and rising cases of diabetes, varicose veins, and foot ulcers in various regions across the globe. According to the estimates of the International Diabetes Federation (IDF), by 2045, approximately 783 million individuals will be living with diabetes. Compression bandages are the gold standard for treating underlying venous insufficiency and managing venous leg ulceration.
Furthermore, the rising studies to assess the effectiveness of compression bandaging are also providing lucrative growth opportunities to the market and supporting the segment's expansion. For instance, an observational study is being conducted to evaluate the effectiveness of compression bandaging in patients suffering from chronic edema. The CIMON sensor is developed for monitoring and placed in the calf's widest circumference, allowing it to measure the difference in capacitance. The study is expected to conclude in December 2025.
Future Market Scenario (2024-2031F)
According to the global compression therapy market analysis, the market is expected to witness significant growth in the coming years owing to rising cases of diabetes, obesity, venous ulcers, lymphedema, and varicose veins, among others. Efforts are being made to improve compression therapy so that clinicians are able to treat their patients in a time-efficient manner while enhancing their comfort. The growing availability of compression products, along with increasing cases of sports-related injuries, are also expected to offer lucrative growth opportunities to the market. The rising investments in research studies are also expected to bolster the growth of the market as these studies aid in examining and assessing the benefits offered by different compression therapies. For instance, the Massachusetts General Hospital is conducting a pilot study on compression sleeve intervention for patients that are at high risk of breast cancer-related lymphedema. The study is expected to conclude in June 2025 and will also have a compression sleeve with a sensor for capturing patient adherence to the pressure applied and compression wear.
Key Players Landscape and Outlook
Strategic collaborations and partnerships are expected to boost the global compression therapy market size in the coming years. In October 2023, MediWound Ltd. announced partnership with 3M COMPANY for phase 3 study of their leading drug candidate EscharEx, indicated for treating patients having venous leg ulcers. The company will be using two-layer compression systems Coban 2 Lite and Coban 2 by 3M during the wound healing and debridement phases of the study. The entry of the topical biologic drug developed for removing nonviable wound tissues for patients with chronic wounds into Phase 3 study is expected to happen in 2024.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work